Sandra Eagle is currently the Senior Director of Drug Development Services, Portfolio Management at ICON plc, a position held since 2017. Previously, Sandra held the roles of Project Manager and Project Director at GlaxoSmithKline from 2000 to 2017. Sandra's career began at SmithKline Beecham Pharmaceuticals, where they served as a Clinical Pharmacology Scientist and later as a Senior Clinical Scientist from 1990 to 2000. Sandra earned a PhD in Biopharmaceutics and a first-class honours BPharm from the University of Bradford, completing their studies in 1989 and 1986, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices